J Korean Med Assoc.  2017 Mar;60(3):257-269. 10.5124/jkma.2017.60.3.257.

Clinical diagnostic guidelines of allergic rhinitis: comprehensive treatment and consideration of special circumstances

• Kim YH
• Lee SM
• Kim MA
• Yang HJ
• Choi JH
• Kim DK
• Yoo Y
• Kim BS
• Kim WY
• Kim JH
• Park SY
• Song K
• Yang MS
• Lee YM
• Lee HJ
• Cho JH
• Jee HM
• Park Y
• Bae WY
• Koh YI
• Work Group for Rhinitis, the Korean Academy of Asthma, Allergy and Clinical Immunology

• KMID: 2374387
• DOI: http://doi.org/10.5124/jkma.2017.60.3.257

Abstract

In order to prevent sensitization to a new allergen and the development of asthma, practitioners may consider allergen-specific immunotherapy in patients with allergic rhinitis. Additionally, in patients with severe allergic rhinitis refractory to medication, practitioners can also consider surgical management for improving the patients' nasal symptoms. However, there are still no practical guidelines regarding the indications for immunotherapy, the appropriate selection of the allergen, and the optimal duration of therapy. Moreover, no clear indications exist for surgical treatment. Pregnant or lactating women frequently complain of symptoms of rhinitis. However, due to the fear of potential complications to their babies, they avoid medical treatment despite significant discomfort. Therefore, we present 14 answers to core questions about immunotherapy, surgical treatment, and considerations for special circumstances, such as pregnancy and lactation.

Keyword

Rhinitis, allergic; Guideline; Surgery; Immunotherapy

MeSH Terms

Asthma
Female
Humans
Immunotherapy
Lactation
Pregnancy
Rhinitis
Rhinitis, Allergic*

Reference

1. Noon L. Prophylactic inoculation against hay fever. Int Arch Allergy Appl Immunol. 1953; 4:285–288.

2. Noon L. Prophylactic inoculation against hay fever: historical document. Ann Allergy. 1960; 18:287–291.

3. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy. 1986; 16:483–491.

4. Hur GY, Kim TB, Kim ST, Han MY, Nahm DH, Lee YW, Sohn SW, Lee HH, Kim WK, Song TW, Kim S, Kim SH, Park JW. Allergy immunotherapy. Korean J Asthma Allergy Clin Immunol. 2010; 30:153–183.

5. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Host A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Moller C. PAT Investigator Group. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006; 61:855–859.

6. Kim SM. Human papilloma virus in oral cancer. J Korean Assoc Oral Maxillofac Surg. 2016; 42:327–336.

7. Zhang Y, Sturgis EM, Li Y, Wei Q, Huang Z, Li G. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Sci Rep. 2017; 7:39765.

8. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med. 2009; 180:936–947.

9. Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2011; 107:79–84.

10. Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017; 231:119–127.

11. Omolehinwa TT, Mupparapu M, Akintoye SO. Incidental finding of an extensive oropharyngeal mass in magnetic resonance imaging of a patient with temporomandibular disorder: a case report. Imaging Sci Dent. 2016; 46:285–290.

12. Riccio C, King K, Elston JB, Harrington MA, Cruse CW. Bilateral plantar verrucous carcinoma. Eplasty. 2016; 16:ic46.

13. Fribley AM, Svider PF, Warner BM, Garshott DM, Raza SN, Kirkwood KL. Recent trends in oral cavity cancer research support in the United States. J Dent Res. 2017; 96:17–22.

14. Joint Task Force on Practice Parameters. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol. 2007; 120:3 Suppl. S25–S85.

15. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006; 117:802–809.

16. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011; 66:740–752.

17. Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract. 2014; 20:225–238.

18. Saporta D. Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health. 2012; 2012:492405.

19. Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013; 131:1361–1366.

20. Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, Canonica GW, Passalacqua G. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy. 2003; 33:206–210.

21. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004; 114:851–857.

22. Marogna M, Tomassetti D, Bernasconi A, Colombo F, Massolo A, Businco AD, Canonica GW, Passalacqua G, Tripodi S. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol. 2008; 101:206–211.

23. Casale TB, Canonica GW, Bousquet J, Cox L, Lockey R, Nelson HS, Passalacqua G. Recommendations for appropriate sublingual immunotherapy clinical trials. J Allergy Clin Immunol. 2009; 124:665–670.

24. Rienzo VD, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica WG, Passalacqua G. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy. 2005; 35:560–564.

25. Patterson ML, Slater JE. Characterization and comparison of commercially available German and American cockroach allergen extracts. Clin Exp Allergy. 2002; 32:721–727.

26. Slater JE, James R, Pongracic JA, Liu AH, Sarpong S, Sampson HA, Satinover SM, Woodfolk JA, Mitchell HE, Gergen PJ, Eggleston PA. Biological potency of German cockroach allergen extracts determined in an inner city population. Clin Exp Allergy. 2007; 37:1033–1039.

27. Passalacqua G. The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence. Curr Opin Allergy Clin Immunol. 2014; 14:20–24.

28. Malling HJ, Montagut A, Melac M, Patriarca G, Panzner P, Seberova E, Didier A. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. Clin Exp Allergy. 2009; 39:387–393.

29. Des Roches A, Paradis L, Knani J, Hejjaoui A, Dhivert H, Chanez P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996; 51:430–433.

30. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy. 2002; 57:306–312.

31. Tabar AI, Arroabarren E, Echechipia S, Garcia BE, Martin S, Alvarez-Puebla MJ. Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy. J Allergy Clin Immunol. 2011; 127:57–63.

32. Tahamiler R, Saritzali G, Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007; 117:965–969.

33. Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012; 129:717–725.

34. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010; 126:969–975.

35. Eifan AO, Shamji MH, Durham SR. Long-term clinical and immunological effects of allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2011; 11:586–593.

36. Wu AW, Ting JY. Indications for surgery in refractory rhinitis. Curr Allergy Asthma Rep. 2014; 14:414.

37. Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han JK, Ishman SL, Krouse HJ, Malekzadeh S, Mims JW, Omole FS, Reddy WD, Wallace DV, Walsh SA, Warren BE, Wilson MN, Nnacheta LC. Guideline Otolaryngology Development Group. AAO-HNSF. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015; 152:1 Suppl. S1–S43.

38. Chhabra N, Houser SM. Surgical options for the allergic rhinitis patient. Curr Opin Otolaryngol Head Neck Surg. 2012; 20:199–204.

39. Kim YH, Kim BJ, Bang KH, Hwang Y, Jang TY. Septoplasty improves life quality related to allergy in patients with septal deviation and allergic rhinitis. Otolaryngol Head Neck Surg. 2011; 145:910–914.

40. Vlastarakos PV, Fetta M, Segas JV, Maragoudakis P, Nikolopoulos TP. Functional endoscopic sinus surgery improves sinus-related symptoms and quality of life in children with chronic rhinosinusitis: a systematic analysis and meta-analysis of published interventional studies. Clin Pediatr (Phila). 2013; 52:1091–1097.

41. Jang TY, Kim YH, Shin SH. Long-term effectiveness and safety of endoscopic vidian neurectomy for the treatment of intractable rhinitis. Clin Exp Otorhinolaryngol. 2010; 3:212–216.

42. Barr JG, Al-Reefy H, Fox AT, Hopkins C. Allergic rhinitis in children. BMJ. 2014; 349:g4153.

43. Scadding GK. Optimal management of allergic rhinitis. Arch Dis Child. 2015; 100:576–582.

44. Barbieri M, Salami A, Mora F, Casazza A, Sovatzis A, Teglia R, Cordone MP, Mora R. Behavior of serum IgE and IgA in patients with allergic rhinitis treated with iodine bromide thermal water. Acta Otorhinolaryngol Ital. 2002; 22:215–219.

45. Cingi C, Unlu HH, Songu M, Yalcin S, Topcu I, Cakli H, Bal C. Seawater gel in allergic rhinitis: entrapment effect and mucociliary clearance compared with saline. Ther Adv Respir Dis. 2010; 4:13–18.

46. Cordray S, Harjo JB, Miner L. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear Nose Throat J. 2005; 84:426–430.

47. Garavello W, Romagnoli M, Sordo L, Gaini RM, Di Berardino C, Angrisano A. Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatr Allergy Immunol. 2003; 14:140–143.

48. Garavello W, Di Berardino F, Romagnoli M, Sambataro G, Gaini RM. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Int Arch Allergy Immunol. 2005; 137:310–314.

49. Garavello W, Somigliana E, Acaia B, Gaini L, Pignataro L, Gaini RM. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol. 2010; 151:137–141.

50. Li H, Sha Q, Zuo K, Jiang H, Cheng L, Shi J, Xu G. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL J Otorhinolaryngol Relat Spec. 2009; 71:50–55.

51. Rogkakou A, Guerra L, Massacane P, Baiardini I, Baena-Cagnani R, Zanella Ch, Canonica GW, Passalacqua G. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis: a randomized controlled study. Eur Ann Allergy Clin Immunol. 2005; 37:353–356.

52. Ural A, Oktemer TK, Kizil Y, Ileri F, Uslu S. Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study. J Laryngol Otol. 2009; 123:517–521.

53. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mosges R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2012; 26:e119–e125.

54. Schafer T, Riehle A, Wichmann HE, Ring J. Alternative medicine in allergies: prevalence, patterns of use, and costs. Allergy. 2002; 57:694–700.

55. Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study. J Altern Complement Med. 2000; 6:519–525.

56. Lundeberg T, Eriksson SV, Theodorsson E. Neuroimmunomodulatory effects of acupuncture in mice. Neurosci Lett. 1991; 128:161–164.

57. Feng S, Han M, Fan Y, Yang G, Liao Z, Liao W, Li H. Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2015; 29:57–62.

58. Lee MS, Pittler MH, Shin BC, Kim JI, Ernst E. Acupuncture for allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2009; 102:269–279.

59. Kern J, Bielory L. Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis. Curr Allergy Asthma Rep. 2014; 14:479.

60. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ. Global Allergy and Asthma European Network. Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010; 126:466–476.

61. Dincer F, Linde K. Sham interventions in randomized clinical trials of acupuncture: a review. Complement Ther Med. 2003; 11:235–242.

62. Ng DK, Chow PY, Ming SP, Hong SH, Lau S, Tse D, Kwong WK, Wong MF, Wong WH, Fu YM, Kwok KL, Li H, Ho JC. A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis. Pediatrics. 2004; 114:1242–1247.

63. Borchers AT, Hackman RM, Keen CL, Stern JS, Gershwin ME. Complementary medicine: a review of immunomodulatory effects of Chinese herbal medicines. Am J Clin Nutr. 1997; 66:1303–1312.

64. Wang S, Tang Q, Qian W, Fan Y. Meta-analysis of clinical trials on traditional Chinese herbal medicine for treatment of persistent allergic rhinitis. Allergy. 2012; 67:583–592.

65. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf. 1999; 20:361–375.

66. Turnbull GL, Rundell OH, Rayburn WF, Jones RK, Pearman CS. Managing pregnancy-related nocturnal nasal congestion: the external nasal dilator. J Reprod Med. 1996; 41:897–902.

67. Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002; 11:146–152.

68. Nelsen LM, Shields KE, Cunningham ML, Stoler JM, Bamshad MJ, Eng PM, Smugar SS, Gould AL, Philip G. Congenital malformations among infants born to women receiving montelukast, inhaled corticosteroids, and other asthma medications. J Allergy Clin Immunol. 2012; 129:251–254.

69. Ellegard EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci. 2001; 26:394–400.

70. Namazy JA, Schatz M. Asthma and rhinitis during pregnancy. Mt Sinai J Med. 2011; 78:661–670.

71. Toll K, Graf P. Phenylpropanolamine's decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness. Rhinology. 2006; 44:274–277.

72. Incaudo GA. Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol. 2004; 27:159–177.

73. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 108:776–789.

74. Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL, Johns DP, Abramson MJ, Hopper JL, Dharmage SC. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007; 120:863–869.

75. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, Wjst M, Cerveri I, Pin I, Bousquet J, Jarvis D, Burney PG, Neukirch F, Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008; 372:1049–1057.

76. Rochat MK, Illi S, Ege MJ, Lau S, Keil T, Wahn U, von Mutius E. Multicentre Allergy Study (MAS) group. Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol. 2010; 126:1170–1175.

77. Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, El Hasnaoui A, Chanal I. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005; 35:728–732.

78. Kulig M, Klettke U, Wahn V, Forster J, Bauer CP, Wahn U. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol. 2000; 106:832–839.

79. Taximaimaiti R, Abuliken X, Maihemuti M, Abudujilile D, Abudulimu H. Elevated Expression of Ox2R in Cervical Cancers and Placentas of Uyghur Women in Xinjiang, China. Asian Pac J Cancer Prev. 2016; 17:4959–4963.

80. Webber CM, England RW. Oral allergy syndrome: a clinical, diagnostic, and therapeutic challenge. Ann Allergy Asthma Immunol. 2010; 104:101–108.